Literature DB >> 10700473

Affiliation to mature B cell repertoire and positive selection can be separated in two distinct processes.

S Hachemi-Rachedi1, A M Drapier, P A Cazenave, P Sanchez.   

Abstract

Using an 'oligoclonal' model, we have previously shown that mice transgenic for a mu chain (H3) and deficient for kappa chain expression display a mature B cell repertoire largely dominated by the H3/lambda1 pair, while the four H3/lambda available combinations can be observed in the immature B cell compartment. This led us to propose the existence of a positive selection process. To test this hypothesis, we have introduced the SJL lambda locus coding for a defective lambda1 chain (lambda1(s)) that creates a dysfunctional Ig receptor complex during B cell differentiation. Our results show that the lambda1(s) defect impairs the development of mature B cells when the H3-mu transgene insert is present in the hemizygous state. This suggests that the Gly --> Val substitution present in the C(lambda)1(s) chain at position 155 is sufficient to abrogate the selection of the H3/lambda1 pair. Unexpectedly, when the H3-mu transgene array is present in a homozygous state in lambda1(s) mice but not in 'wild-type' lambda1 mice (lambda1(+)), a significant number of mature B cells expressing all H3/lambda combinations can be developed. These results indicate that the overriding H3/lambda1 dominance observed in lambda1(+) mice is due to a positive selection process and not to a negative selection of other H3/lambda combinations. They also show that the export of B cells to the periphery can be controlled by the expression of the mu chain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700473     DOI: 10.1093/intimm/12.3.385

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  1 in total

1.  Alternative mechanisms of receptor editing in autoreactive B cells.

Authors:  Olga Kalinina; Colleen M Doyle-Cooper; Jennifer Miksanek; Wenzhao Meng; Eline Luning Prak; Martin G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-06       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.